ABBV-154, an antibody-drug conjugate comprising adalimumab conjugated to a proprietary glucocorticoid receptor modulator, shows potential for extending flare-free periods in patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback